DNA sequencing contains information about genetically determined illness
and IQ level of human beings. Increasing adoption of precision medicines and
increasing use of other applications such as biotechnology, forensic biology,
virology, and molecular biology are factors which are driving the growth of
this market. The rise in investment in research and development enhances the
demand for DNA sequencing and hence helps to increase market growth. The
enzymic method for DNA sequencing has been used for genomic research and as
accurate results were obtained by this method the demand for DNA sequencing has
increased. This demand has driven the development of the second-generation
sequencing method.
The DNA
Sequencing Market is expected to boost USD 4870
million during the estimated the forecasting year of 2022-2030
However, the lack of reimbursement policies in various countries across
the world may limit the growth of DNA Sequencing
Market during the forecast period.
Major Key Players:
Some of the DNA Sequencing Market Players are Perkin Elmer, Roche
Holdings AG, Siemens AG, Illumina, Agilent Technologies Inc., Genia
Corporation, Oxford Nanopore technologies, Koninklijke Philips N.V., Pacific
Biosciences, Johnson & Johnson, Deep Genomics, Inc., Life Technologies,
Illumina, Eppendorf, Tecan, and Thermo Scientific, Hamilton Thorne Biosciences,
General Electric Company, Siemens Healthineers GmbH, Myriad Genetics, Bayer
Corporation, Beckman Coulter, and others.
Segment Analysis
The global DNA sequencing market has been segmented
on the basis of type, product, technology, application, and end-users. On the
basis of type, the market is segmented into instruments and consumables
services and workflow products. Based on product the market is segmented into
sequencing services and sequencing instruments and consumables. Sequencing
instruments and consumables are further sub-segmented into two types such as
sequencing instruments and consumables by product type and by platform type.
Sequencing instruments and consumables by product type are further
sub-segmented into consumables, instruments, whereas sequencing instruments and
consumables by platform type are further sub-segmented into NGS, sanger,
bioinformatics, sample prep kits, and reagents. On the basis of technology, the
market is further segmented into dna modifying enzymes, semiconductor
sequencing, pyrosequencing, sequencing by synthesis, single-molecule real-time
sequencing (SMRT), sequencing by ligation (SBL), and other technologies. On the
basis of application, the market is further segmented into diagnostics,
agriculture and animal research, biomarker discovery, personalized medicine,
drug discovery, and other applications. Based on end-user, the market is
segmented into research centers and government institutes and academia, biotechnology
and pharmaceutical companies, clinics and hospitals, and other end-users.
The market has been segmented, by region, into the
Americas, Europe, Asia-Pacific, and the Middle East and Africa.
Regional Analysis
The market in the Americas is
expected to boost the global DNA sequencing market owing to technological
advancements and increasing incidences of genetic disorders among patients.
Increasing investments by government organizations in the research and development
of DNA sequencing are also boosting the market growth in this region. The
European market is expected to be the second-largest due to government funding
and support from the healthcare sector coupled with the rising prevalence of
the genetic disorder. However, Asia-Pacific is projected to dominate in terms
of growth rate over the forecast period owing to the rising investment towards
R&D activities and unhealthy lifestyle which are resulting in an increased
prevalence of cancer and other disorders. Rising geriatric population and
increasing prevalence of tumor among patients in this region have a positive
influence on the development of DNA sequencing market in this region. The
Middle East and Africa accounts for the smallest share due to lack of medical
technology and poor medical facilities. Emerging economies such as India and
China are leading to growth in the demand for DNA sequencing owing to an
increasing number of healthcare awareness programs, government investments in
healthcare, and favorable healthcare insurance coverage.
About Market Research
Future
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients. Our
market research studies by products, services, technologies, applications, end
users, and market players for global, regional, and country level market
segments, enable our clients to see more, know more, and do more, which help to
answer all their most important questions.
In order to stay updated with technology and work
process of the industry, MRFR often plans & conducts meet with the industry
experts and industrial visits for its research analyst members.
Contact us:
Market Research Future
(part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 646 845 9312
